IRM vs LAB · P/E 136, rev $6.15B vs rev $174.4M
Iron Mountain Incorporated (IRM) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
IRM currently screens at market cap $37.09B and trailing P/E 135.5. LAB currently screens at market cap $317.1M.
Not investment advice. Open the IRM and LAB stock pages for the full models.
Not investment advice.